PXD023341 is an
original dataset announced via ProteomeXchange.
Dataset Summary
Title | Proteomic identification of recombinant nucleocapsid N protein 40 kDa fragment from SARS-CoV-2 |
Description | Serological testing is important methodfor diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Nucleocapsid (N) protein is the most abundant virus derived protein and strong immunogen. We aimed to find its efficient, low-cost production. SARS-CoV-2 recombinant fragment of nucleocapsid protein (rfNP; 58-419 aa) was expressed in E. coli in soluble form, purified and characterized biochemically and immunologically. Purified rfNP has secondary structure of full-length recombinant N protein, with high percentage of disordered structure (34.2 %) and of β-sheet (40.7 %). rfNP was tested in immunoblot using sera of COVID-19 convalescent patients. ELISA was optimized with sera of RT-PCR confirmed positive symptomatic patients and healthy individuals. IgG detection sensitivity was 96% (47/50) and specificity 97% (67/68), while IgM detection was slightly lower (94% and 96.5%, respectively). Cost-effective approach for soluble recombinant N protein fragment production was developed, with reliable IgG and IgM antibodies detection of SARS-CoV-2 infection. |
HostingRepository | PRIDE |
AnnounceDate | 2021-02-17 |
AnnouncementXML | Submission_2021-02-16_22:42:04.xml |
DigitalObjectIdentifier | https://dx.doi.org/10.6019/PXD023341 |
ReviewLevel | Peer-reviewed dataset |
DatasetOrigin | Original dataset |
RepositorySupport | Supported dataset by repository |
PrimarySubmitter | Katarina Smiljanic |
SpeciesList | scientific name: SARS coronavirus Sin3765V; NCBI TaxID: 267386; |
ModificationList | carbamoylated residue; dehydrated residue; acetylated residue; monohydroxylated residue; monosodium salt; iodoacetamide derivatized residue; deamidated residue |
Instrument | LTQ Orbitrap XL |
Dataset History
Revision | Datetime | Status | ChangeLog Entry |
0 | 2021-01-04 00:04:46 | ID requested | |
⏵ 1 | 2021-02-16 22:42:04 | announced | |
Publication List
Djukic T, Mladenovic M, Stanic-Vucinic D, Radosavljevic J, Smiljanic K, Sabljic L, Devic M, Cujic D, Vasovic T, Simovic A, Radomirovic M, Cirkovic Velickovic T, Expression, purification and immunological characterization of recombinant nucleocapsid protein fragment from SARS-CoV-2. Virology, 557():15-22(2021) [pubmed] |
Keyword List
ProteomeXchange project tag: Sars-cov-2, Covid-19 |
submitter keyword: Recombinant nucleocapsid protein, N protein fragment, covid-19, SARS-CoV-2, prokaryotic expression;serological assay |
Contact List
Tanja D. Ćirković Velicković |
contact affiliation | Tanja Ćirković Velicković, PhD Professor of Biochemistry & Corresponding member of Serbian Academy of Sciences and Arts University of Belgrade-Faculty of Chemistry, Center of Excellence for Molecular Food Sciences and Department of Biochemistry, Studentski trg 12-16, 11 000 Belgrade, Serbia. Professor of Food Chemistry Department of Environmental Technology, Food Technology and Molecular Biotechnology, Ghent University Global Campus, Yeonsu-Gu, 21985 Incheon, Republic of Korea |
contact email | tcirkov@chem.bg.ac.rs |
lab head | |
Katarina Smiljanic |
contact affiliation | Senior Research Associate at University of Belgrade-Faculty of Chemistry, Center of Excellence for Molecular Food Sciences |
contact email | katarinas@chem.bg.ac.rs |
dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/02/PXD023341 |
PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD023341
- Label: PRIDE project
- Name: Proteomic identification of recombinant nucleocapsid N protein 40 kDa fragment from SARS-CoV-2